Effect of Tribendimidine on Strongyloides ratti
Author Information
Author(s): Jennifer Keiser, Kai Thiemann, Yvette Endriss, Jürg Utzinger
Primary Institution: Swiss Tropical Institute, Basel, Switzerland
Hypothesis
Does tribendimidine exhibit activity against Strongyloides ratti in vitro and in vivo?
Conclusion
Tribendimidine shows significant activity against Strongyloides ratti in both laboratory and animal studies.
Supporting Evidence
- Tribendimidine killed S. ratti larvae in vitro within 24 hours at certain concentrations.
- A single dose of 50 mg/kg tribendimidine eliminated adult S. ratti in infected rats.
- Tribendimidine was less effective against younger stages of S. ratti.
Takeaway
Tribendimidine can kill a type of worm that causes disease in humans, and it works better than some other medicines.
Methodology
The study involved in vitro tests on larvae and in vivo tests on infected rats to assess the effectiveness of tribendimidine.
Limitations
The study primarily used animal models, and results may not directly translate to humans.
Participant Demographics
Male Wistar rats, age: 3 weeks, weight: ∼80 g.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website